122 related articles for article (PubMed ID: 8971079)
1. Autoantibodies to IA-2 in IDDM: location of major antigenic determinants.
Zhang B; Lan MS; Notkins AL
Diabetes; 1997 Jan; 46(1):40-3. PubMed ID: 8971079
[TBL] [Abstract][Full Text] [Related]
2. Comparison of IA-2 with IA-2beta and with six other members of the protein tyrosine phosphatase family: recognition of antigenic determinants by IDDM sera.
Notkins AL; Zhang B; Matsumoto Y; Lan MS
J Autoimmun; 1997 Jun; 10(3):245-50. PubMed ID: 9218750
[TBL] [Abstract][Full Text] [Related]
3. Identification of a second transmembrane protein tyrosine phosphatase, IA-2beta, as an autoantigen in insulin-dependent diabetes mellitus: precursor of the 37-kDa tryptic fragment.
Lu J; Li Q; Xie H; Chen ZJ; Borovitskaya AE; Maclaren NK; Notkins AL; Lan MS
Proc Natl Acad Sci U S A; 1996 Mar; 93(6):2307-11. PubMed ID: 8637868
[TBL] [Abstract][Full Text] [Related]
4. Autoantigens in insulin-dependent diabetes mellitus: molecular cloning and characterization of human IA-2 beta.
Li Q; Borovitskaya AE; DeSilva MG; Wasserfall C; Maclaren NK; Notkins AL; Lan MS
Proc Assoc Am Physicians; 1997 Jul; 109(4):429-39. PubMed ID: 9220540
[TBL] [Abstract][Full Text] [Related]
5. The 37/40-kilodalton autoantigen in insulin-dependent diabetes mellitus is the putative tyrosine phosphatase IA-2.
Passini N; Larigan JD; Genovese S; Appella E; Sinigaglia F; Rogge L
Proc Natl Acad Sci U S A; 1995 Sep; 92(20):9412-6. PubMed ID: 7568143
[TBL] [Abstract][Full Text] [Related]
6. IA-2, a transmembrane protein of the protein tyrosine phosphatase family, is a major autoantigen in insulin-dependent diabetes mellitus.
Lan MS; Wasserfall C; Maclaren NK; Notkins AL
Proc Natl Acad Sci U S A; 1996 Jun; 93(13):6367-70. PubMed ID: 8692821
[TBL] [Abstract][Full Text] [Related]
7. Identification of the 37-kDa antigen in IDDM as a tyrosine phosphatase-like protein (phogrin) related to IA-2.
Hawkes CJ; Wasmeier C; Christie MR; Hutton JC
Diabetes; 1996 Sep; 45(9):1187-92. PubMed ID: 8772720
[TBL] [Abstract][Full Text] [Related]
8. Autoantibodies to IA-2 and IA-2 beta in insulin-dependent diabetes mellitus recognize conformational epitopes: location of the 37- and 40-kDa fragments determined.
Xie H; Zhang B; Matsumoto Y; Li Q; Notkins AL; Lan MS
J Immunol; 1997 Oct; 159(7):3662-7. PubMed ID: 9317167
[TBL] [Abstract][Full Text] [Related]
9. Cross reactivity between IA-2 and phogrin/IA-2beta in binding of autoantibodies in IDDM.
Hatfield EC; Hawkes CJ; Payton MA; Christie MR
Diabetologia; 1997 Nov; 40(11):1327-33. PubMed ID: 9389426
[TBL] [Abstract][Full Text] [Related]
10. Human monoclonal antibodies isolated from type I diabetes patients define multiple epitopes in the protein tyrosine phosphatase-like IA-2 antigen.
Kolm-Litty V; Berlo S; Bonifacio E; Bearzatto M; Engel AM; Christie M; Ziegler AG; Wild T; Endl J
J Immunol; 2000 Oct; 165(8):4676-84. PubMed ID: 11035111
[TBL] [Abstract][Full Text] [Related]
11. Autoantibodies in insulin-dependent diabetes recognize distinct cytoplasmic domains of the protein tyrosine phosphatase-like IA-2 autoantigen.
Lampasona V; Bearzatto M; Genovese S; Bosi E; Ferrari M; Bonifacio E
J Immunol; 1996 Sep; 157(6):2707-11. PubMed ID: 8805677
[TBL] [Abstract][Full Text] [Related]
12. Autoantibodies to protein tyrosine phosphatase-like proteins in type I diabetes. Overlapping specificities to phogrin and ICA512/IA-2.
Kawasaki E; Eisenbarth GS; Wasmeier C; Hutton JC
Diabetes; 1996 Oct; 45(10):1344-9. PubMed ID: 8826969
[TBL] [Abstract][Full Text] [Related]
13. Novel fusion proteins in the analysis of diabetes-associated autoantibodies to GAD65 and IA-2.
Zavialov A; Ankelo M; Westerlund-Karlsson A; Knip M; Ilonen J; Hinkkanen A
J Immunol Methods; 2000 Dec; 246(1-2):91-6. PubMed ID: 11121550
[TBL] [Abstract][Full Text] [Related]
14. IA-2 and IA-2beta: the immune response in IDDM.
Notkins AL; Lan MS; Leslie RD
Diabetes Metab Rev; 1998 Mar; 14(1):85-93. PubMed ID: 9605631
[TBL] [Abstract][Full Text] [Related]
15. Expression, characterization, processing and immunogenicity of an insulin-dependent diabetes mellitus autoantigen, IA-2, in Sf-9 cells.
Xie H; Deng YJ; Notkins AL; Lan MS
Clin Exp Immunol; 1998 Sep; 113(3):367-72. PubMed ID: 9737664
[TBL] [Abstract][Full Text] [Related]
16. The relationship between humoral and cellular immunity to IA-2 in IDDM.
Ellis TM; Schatz DA; Ottendorfer EW; Lan MS; Wasserfall C; Salisbury PJ; She JX; Notkins AL; Maclaren NK; Atkinson MA
Diabetes; 1998 Apr; 47(4):566-9. PubMed ID: 9568688
[TBL] [Abstract][Full Text] [Related]
17. IA-2 (islet cell antigen 512) is the primary target of humoral autoimmunity against type 1 diabetes-associated tyrosine phosphatase autoantigens.
Bonifacio E; Lampasona V; Bingley PJ
J Immunol; 1998 Sep; 161(5):2648-54. PubMed ID: 9725268
[TBL] [Abstract][Full Text] [Related]
18. Mapping of novel autoreactive epitopes of the diabetes-associated autoantigen IA-2.
Seissler J; Schott M; Morgenthaler NG; Scherbaum WA
Clin Exp Immunol; 2000 Nov; 122(2):157-63. PubMed ID: 11091269
[TBL] [Abstract][Full Text] [Related]
19. Autoantibodies to IA-2 in insulin-dependent diabetes mellitus. Measurements with a new immunoprecipitation assay.
Masuda M; Powell M; Chen S; Beer C; Fichna P; Rees Smith B; Furmaniak J
Clin Chim Acta; 2000 Jan; 291(1):53-66. PubMed ID: 10612717
[TBL] [Abstract][Full Text] [Related]
20. Relationship of the 37,000- and 40,000-M(r) tryptic fragments of islet antigens in insulin-dependent diabetes to the protein tyrosine phosphatase-like molecule IA-2 (ICA512).
Payton MA; Hawkes CJ; Christie MR
J Clin Invest; 1995 Sep; 96(3):1506-11. PubMed ID: 7657822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
